Overview

Study to Evaluate a Pegcetacoplan (Syfovre) Prefilled Syringe

Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 3, open-label study to evaluate the safety of pegcetacoplan in a prefilled syringe (PFS)
Phase:
PHASE3
Details
Lead Sponsor:
Apellis Pharmaceuticals, Inc.
Treatments:
pegcetacoplan